About REGONAT 40MG TAB
Regonat Tablet is a Tyrosine kinase inhibitors used in the treatment of cancer of colon and rectum.Regonat Tablet should be taken with food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include infection, low blood platelets, anemia, decreased appetite, hemorrhage, and high blood pressure. It can also cause voice change, diarrhea, stomatitis, vomiting, nausea, bilirubin in urine, increased liver enzyme, rash, weakness, pain, fever, mucosal inflammation, and weight loss. If any of these side effects bother you, let your doctor know. Regular blood tests are required to check your blood cells along with liver functioning.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.Powerful Anticancer TherapyREGONAT 40MG TAB offers a targeted approach to treating metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. Its active ingredient, regorafenib, works by inhibiting multiple kinases that promote tumor growth and angiogenesis, offering patients a proven therapeutic option when other treatments may have been exhausted.
Usage and Dosage GuidelinesThis medicine is designed for adult patients under oncologist supervision. The usual dosage is 160 mg (four 40 mg tablets) taken once daily for 21 consecutive days, followed by a 7-day break, constituting one cycle. The tablets must be swallowed whole with a light, low-fat meal. Do not crush or chew the tablets.
Safety and StorageREGONAT 40MG TAB should be stored below 30C, away from moisture and light to maintain its efficacy. As with many anticancer medications, it may cause side effects such as hypertension, fatigue, diarrhea, or liver toxicity. It is essential to consult your doctor for regular monitoring and to report any adverse symptoms promptly.
FAQ's of REGONAT 40MG TAB:
Q: How should REGONAT 40MG TAB be taken for optimal effectiveness?
A: REGONAT 40MG tablets should be swallowed whole, not crushed or chewed, and taken once daily with a light, low-fat meal. Follow your oncologist's dosage instructions carefully-typically 160 mg daily for 21 days followed by 7 days off.
Q: What specific conditions is REGONAT 40MG TAB prescribed for?
A: This medicine is intended for adults with metastatic colorectal cancer, advanced gastrointestinal stromal tumors, or hepatocellular carcinoma that cannot be treated with surgery or have not responded to other treatments.
Q: When is it necessary to consult a doctor while using REGONAT 40MG TAB?
A: Consult your oncologist immediately if you experience side effects such as high blood pressure, severe fatigue, hand-foot skin reaction, persistent diarrhea, or signs of liver toxicity, as regular monitoring is crucial during this therapy.
Q: Where should REGONAT 40MG TAB be stored to preserve its quality?
A: Keep the tablets in their original packaging, stored below 30C, away from moisture and light. This helps maintain the medication's effectiveness for up to 24 months from the manufacture date.
Q: What is the process for obtaining REGONAT 40MG TAB?
A: REGONAT 40MG TAB is available strictly on prescription and must be obtained from a pharmacy or distributor authorized to sell oncology medications, with a prescription provided by an oncologist or cancer specialist.
Q: How does REGONAT 40MG TAB benefit cancer patients?
A: Regorafenib, the active component, inhibits multiple enzymes called kinases involved in cancer cell division and blood vessel growth to tumors, thereby helping slow the progression of advanced cancers and potentially improving patient outcomes.